Fertilitysa.com.au
LAUNCH OF PCOS CLINICS FOR
FERTILITy PATIENTS – SEPTEMBER 2011
Approximately 20% of women presenting
Prof Norman is the leading expert on PCOS
for fertility treatment have polycystic
and infertility in Australia and was part
ovarian syndrome (PCOS). As the New
of the team that developed the NHMRC
NHMRC Guidelines for the assessment
guidelines for PCOS. The following is a
and management of polycystic ovarian
summary of the recommendations from
syndrome are being launched this year
the Guidelines. These guidelines will be
Welcome to our new format Fertility SA
by the PCOS Alliance and Jean Hailes
published on the Jean Hailes Foundation
Newsletter. It has been a wonderful
Foundation for Women's Health
few months; our success rates continue
we would like to provide you with
to be well above national and
an update of the fertility options
international benchmarks; patient
available for women with PCOS
feedback has been fantastic and we
at Fertility SA.
are very excited about the launch of
Most of the fertility issues faced by
our specialist fertility clinics for patients
women with the condition centre
with Polycystic Ovarian Syndrome in
around anovulation (a condition
September this year.
where eggs are not released from the ovaries appropriately).
We hope you enjoy reading our news
While some women with PCOS
but if you have any suggestions for
will ovulate intermittently and
improving the content, please contact
become pregnant spontaneously,
our General Manager, Lee Battye.
ovulation is often not regular and can make intercourse timing
On behalf of all our fertility specialists –
difficult. Ovulation kits may
Dr Alex Hubczenko, Dr Louise Hull,
not be effective as hormonal
Prof Rob Norman, A/Prof Ossie
changes associated with PCOS
Petrucco, Dr Michelle Wellman and
(consistently high LH levels) can
me – thanks for your support.
interfere with their readings. Fertility treatments for PCOS
include lifestyle modification, ovulation induction with Clomid,
FSH and metformin, and where required, IVF.
In September 2011, Fertility SA will support
website from 28th August 2011. The
dedicated infertility clinics for PCOS
guidelines emphasise lifestyle management
Fertility SA Consulting Clinic
patients as we believe that patients with
and weight loss particularly in women with
PCOS are in particular need of specialist
a BMI greater than 35. No particular
345 Carrington Street
gynaecological attention to manage their
diet has been found to be more effective
fertility treatment options. These clinics
in the treatment of PCOS and the
For all appointments & enquiries
will be run by Dr Michelle Wellman and
recommendation is to reduce dietary energy
Professor Rob Norman who have a special
(caloric) intake in the setting of healthy
Phone (08) 8100 2900
interest and vast experience in the fertility
Fax (08) 8223 1319
management of PCOS.
Continued next page.
Personalised care by leading fertility specialists
monitoring these cycles in order to optimise
used for women who do not respond to
outcome and to reduce the risk of
clomiphene. In some situations they can
multiple pregnancy.
be used as first line. These ovulation induction cycles often require more intense
This is generally a low risk and low cost
ontinued from previous page.
education, supervision and monitoring to
treatment. The rates of twin pregnancy
A referral to a dietician may enhance the
and triplets with clomiphene citrate are
primary infertility care plan.
5 - 7% and 0.3%, respectively.
Again, our team at Fertility SA are highly
key messages for women with PCOS are
experienced in the management of
The incidence of ovarian hyper-stimulation
that achievable weight loss goals (such
these cycles.
syndrome (OHSS) is less than 1%.
as 5% to 10% loss of body weight) yield
Studies with clomiphene citrate have
significant clinical improvements.
shown an ovulation rate of 60 - 85%
At least 150 minutes of exercise per week
and a pregnancy rate of 30 - 50% after
is recommended, and 90 minutes per
6 ovulatory cycles.
week of this should be aerobic activity at moderate to high intensity (60% - 90%
Case Study - Fertility SA Patient B
of maximum heart rate) .
A patient with PCOS who had several
Behavioural change techniques, including
clomiphene citrate cycles without success
motivational interviewing are advocated
was referred to Fertility SA for fertility
in addition to providing information and
treatment. A further clomiphene citrate
education. Interventions can be individual,
cycle was monitored very closely with blood
group or mixed mode, in a range of
tests and scans. An injection to induce
settings, delivered by a range of health
ovulation was given at the time the follicle
had developed to the correct size and timed intercourse recommended. An
Case Study - Fertility SA Patient A
ongoing pregnancy resulted, much to
A 43 year old patient with PCOS and a
the patient's delight.
BMI of 42 had had numerous cycles of
Take home message: when clomiphene
IVF and ovulation induction over a 15 year
does not appear to work, referral for
period of time. After review at Fertility SA,
closer hormonal tracking and possible
an intensive lifestyle management plan
intercourse timing should be considered.
was instituted for both partners. Another IVF cycle was planned but
There has been some confusion as to the
cancelled when a positive pregnancy test
place of metformin in the treatment of
was found. A single fetal heart was seen
women with PCOS and infertility. It should
on a subsequent scan.
not be used as a substitute for lifestyle change. Contrary to what was initially
Take home message: Lifestyle
Our nursing staff are available to answer
thought, metformin appears to be more
management should be applied even
any questions about these cycles and
effective in restoring ovulation in women
if IVF is planned. Patient spent many
provide instruction on administration
with a BMI less than 30 if used alone.
hundreds of thousands of dollars on
and timing of medication. It is rare for
fertility treatment when correct advice
It may be effective in improving response
women with PCOS not to respond to
could have worked.
to Clomid in those women who may appear
clomiphene resistant regardless of BMI.
The recommended first line
Occasionally cycles may need to be
pharmacological treatment for PCOS is
Ovulation induction with gonadotropins
recommenced if there is an over-response
clomiphene citrate. The staff at Fertility SA
(subcuticular injections of FSH, trade
to medication, in order to avoid multiple
have extensive experience in tracking and
names Puregon or Gonal F) are generally
Case Study - Fertility SA Patient C
PCOS INFORMATION SESSIONS
A 26 year old anovular patient with PCOS
Professor Norman and Dr Wellman will be providing an update for doctors on the new
and a normal BMI was previously seen by
guidelines in September 2011 and are planning a public information session for PCOS
an IVF clinic who recommended IVF.
fertility patients soon afterwards.
She was commenced on a standard dose
Professor Norman will also be conducting a general information session for PCOS
of FSH, become severely hyper-stimulated
patients in conjunction with the Jean Hailes Foundation and Women's and Children's
and was admitted to hospital for several
Hospital in October 2011.
weeks without a pregnancy. She vowed never to have IVF again. At Fertility SA we
Doctors seeking a specialist opinion for their PCOS patients who are not concerned with
commenced ovulation induction with a very
fertility issues may refer patients to Professor Norman at his clinic at the Royal Adelaide
low dose of FSH seeking to develop one
Hospital. Doctor Michelle Wellman is happy to provide initial advice and ongoing
follicle and time intercourse without IVF
management plan through her rooms in North Adelaide.
treatment. She was very happy when she became pregnant and a single fetus was seen on an ultrasound scan.
Take home message: PCOS and infertility
FRANZCOG FRCPA CREI
should be seen by a person with
experience in other forms of fertility
• Fertility Specialist
• Fertility Specialist
management and who is skilled in
• Specialist Surgical
• Reproductive
ovulation induction. IVF can be risky
Endocrinologist
for patients with PCOS.
Often laparoscopy is performed as part of the assessment of infertility. As a number
the ability of the sperm to fertilise the egg
at Fertility SA, it was clear that because of
of our specialists have extensive experience
in vivo! However if IVF is needed, Fertility
her husband's low sperm count, IVF was still
in laparoscopic surgery, women with
SA has an outstanding pregnancy rate in
the best fertility treatment.
PCOS can be advised if this is appropriate
these patients.
management for them. Laparoscopic
A final IVF cycle was monitored closely and
ovarian drilling may also be an option in
CASE STUDY- Fertility SA Patient D
several careful dose adjustments were made
women who fail to respond to clomiphene.
during the cycle. The ovaries responded
A patient with PCOS undertook IVF
This procedure may restore ovulation in up
appropriately and the patient became
because her partner had a low sperm count.
to 60 - 80% of women with PCOS and can
pregnant.
In her first cycle, multiple follicles developed
sometimes be offered as an alternative to
and although she conceived, she developed
She was monitored closely as an outpatient
FSH ovulation induction or IVF.
severe over hyperstimulation syndrome
in early pregnancy by her own doctor at
If women do not respond to these
requiring admission to a public hospital, IV
both Fertility SA's consulting rooms and at
more simple treatments or there are
fluid therapy, catheterisation and drainage
St Andrews Hospital but did not develop
other infertility factors, IVF may be an
of ascites (an abdominal fluid collection).
hyperstimulation syndrome. A single live
appropriate course of treatment. Caution
Unfortunately the pregnancy miscarried.
fetus was identified at an 8 week
however needs to be exercised as women
pregnancy scan.
Another IVF cycle was cancelled because
with PCOS are at significantly increased
of over response, then in a third IVF cycle
Take home message: For women
risk of ovarian hyper-stimulation syndrome.
there were some difficulties obtaining
with PCOS that require IVF, careful
For this reason, even if there appears to be
medical advice and the dose was initially
monitoring, continuity of care and
an abnormal semen analysis, more simple
too low, then increased to a level that again
specialist medical input is required during
and safer techniques are often better used
resulted in an over response of the ovaries
an IVF cycle and in early pregnancy,
first line. The best test of male fertility is
and a cancelled cycle. After seeking advice
to minimise hyperstimulation.
Personalised care by leading fertility specialists
Our success rates for the period ending 31st March 2011 are shown
in the opposite graph. This demonstrates clearly that our success rates
are outstanding by comparison to national and international
benchmarks. However, success rates do not tell the whole story and
for some patients, the dream of having a baby will not become a reality.
For this reason, we hold regular in-house education meetings, learn
about the latest innovations at national and international conferences,
run several research projects and promote the use of new techniques
and technologies to ensure that we remain at the cutting edge of
Clinical heart beat
developments to help enhance the prospects of pregnancy for our patients.
GENERAL MANAGER'S UPDATE from the desk of Lee Battye
ESHRE CONFERENCE, STOCkHOLM
Professor Norman gave a plenary lecture to 4,000 participants at the European Society
Consulting locations –
for Human Reproduction and Embryology (ESHRE). ESHRE is one of the two premier
For patients' convenience,
organisations on IVF and reproduction.
Dr Alex Hubczenko consults from Calvary Central District Hospital, 25-37 Jarvis Rd,
Professor Norman's speech was entitled "Redefining success of assisted reproductive
Elizabeth Vale every fortnight and Dr Ossie
technology: how do we assess the best results?" In it, he pointed out that success is more than
Petrucco holds consultations for country
claiming high pregnancy rates - live birth, fresh and frozen results, a low multiple rate and
patients periodically at various locations
high patient satisfaction are also important.
in South Australia and Darwin.
He defined the PERFECT clinic as one with high pregnancy rates, the best trained
Dr Jodie Semmler and Dr Michelle
gynaecological specialists, a high investment in education and research, a strong focus on
Wellman also consult from their respective
patient care, emotional engagement, outstanding controlled quality systems and truth in
private rooms in North Adelaide.
all aspects of patient care, results, effective treatments and marketing. Fertility SA has
All of our specialists also consult from our
set its standards to be among the very few elite units in the world to achieve all these
rooms at 345 Carrington St, Adelaide.
goals and has a clear plan to excel in all these areas.
PATIENT SATISFACTION SURVEyS
New brochure – Some of you may have
already seen our new brochure for patients.
If you would like more brochures or any
We have been thrilled with feedback from our patients, with 92% of patient responses
other materials, please contact myself or
rating our overall service as good or excellent and 94% of respondents saying they would
Janet McBride on (08) 8100 2900.
recommend our clinic to a friend or family member.
Welcome - We are delighted to be
Patient comments mainly centre on the friendly, supportive and personalised service
welcoming Jo Patterson and Jane Gard
we provide and many patients have contrasted this to the "production line" they have
to our nursing team, Rochelle Owens to
experienced elsewhere. We are aiming to improve this even further and to this end we
our admin team and Meghan Inge to our
have recently been gathering feedback from referring doctors as well.
laboratory team. Sadly, one of our lovely
We understand that occasionally we may not meet our desired service levels however
fertility nurses Rosie Bell will be leaving
and if you have an experience that you would like to share, please contact me
later this year to return to Victoria and
on (08) 8100 2900.
she will be greatly missed by all of us.
Source: http://www.fertilitysa.com.au/wp-content/uploads/2016/03/Fertility-SA-Focus-Newsletter-Issue-2.pdf
Orbt.pdf
Prof. Dr. Thomas Koller II VORLESUNG ZUM OBLIGATIOENRECHT BT 1. TEIL: VORBEMERKUNGEN UND INNOMINATKONTRAKTE A Aufbau und Funktion des OR BT I. Aufbau II. Funktion • Rationalisierung Die meisten Verträge passen in einen der gesetzlichen Vertragstypen, dies trotz der Vertragstypenfreiheit. Es ist möglich, einen Vertrag bewusst oder unbewusst lücken-haft zu belassen, weil man darauf vertrauen kann, dass Detailfragen bereits im Ge-setz geregelt sind. Der Aufwand bei Vertragsschluss kann so erheblich gesenkt wer-den.
Icss protocol
The 2nd European Carotid Surgery Trial (ECST-2) Protocol Version 2.00 1 May 2013 International Standard Randomised Controlled Trial Number: ISRCTN97744893 ECST-2 Protocol v 2.0 – page 2 CONTENTS ECST-2 Protocol v 2.0 – page 3 PROTOCOL SUMMARY BACKGROUND Randomised trials have established the benefit of revascularisation by carotid endarterectomy (CEA) for moderate and severe carotid stenosis. However, a risk model derived from one of these trials and validated in another, showed that only patients with a high risk of stroke under medical therapy benefited from CEA. For a large range of patients there was neither clear benefit nor harm from CEA. Medical therapy for stroke prevention has improved since these original trials, with more widespread use of statins, more active lowering of blood pressure and more effective antiplatelet regimes. Lower optimum targets have been set for risk factor control e.g. blood pressure. Therefore CEA may not be beneficial in many patients with carotid stenosis treated by modern optimized medical therapy (OMT). HYPOTHESIS We hypothesize that in patients with carotid stenosis at low and intermediate risk for stroke, OMT alone is as effective in the long-term prevention of cerebral infarction and myocardial infarction (MI) as revascularisation and OMT combined. STUDY DESIGN ECST-2 is a multicentre, randomised, controlled, open, prospective clinical trial with blinded outcome assessment. We will use a risk model based on clinical characteristics to calculate a 5-year Carotid Artery Risk (mCAR) score, which will stratify patients as at high risk (≥15%), intermediate risk (7.5-15%), or low risk (<7.5%) of future stroke using predictive data from previous trials recalibrated to take account of the likely benefit of OMT. An interim analysis using MRI to determine the 2-year rates of cerebral infarction and haemorrhage after randomisation will be performed to assess safety and feasibility of the design and inform the design and sample size calculations for the full trial. ECST-2 will incorporate baseline imaging of carotid plaque where possible to investigate the predictive value of plaque characteristics. CENTRE REQUIREMENTS A neurologist or physician with an interest in stroke; a surgeon with expertise in CEA; if available, an interventionist with expertise in CAS. Access to MRI. INCLUSION CRITERIA Patients with symptomatic or asymptomatic atherosclerotic carotid artery stenosis (> 50%, NASCET criteria), suitable for revascularisation with CAR score indicating low or intermediate risk. MAIN EXCLUSION CRITERIA Patients with a CAR score indicating high risk, patients refusing either treatment, unable to consent or unsuitable for revascularisation due to anatomy, ill-health or disabling stroke (current Rankin >2). Recent contralateral carotid revascularisation, cardiac or other major surgery. RANDOMISATION AND TREATMENTS Patients will be randomly allocated in equal proportions to be treated by 1) immediate carotid revascularisation with OMT or 2) OMT alone (in the latter arm, revascularisation may be performed at a later stage if it becomes more clearly indicated e.g. because of TIA during follow up). Randomisation will be stratified by centre, type of planned revascularisation, symptom status and CAR score. A web-based randomisation system will be used. We anticipate that revascularisation will be by CEA in most patients, but carotid stenting (CAS) may be used if considered more appropriate. Centres will prespecify whether a patient will receive CEA or CAS if allocated to revascularisation. Randomisation and analysis will be stratified by the pre-specified intervention. The randomisation form will include entry of data to confirm a CAR score of <15%. OMT in both arms will consist of all three of: 1) optimal antiplatelet therapy; 2) statin or other cholesterol lowering treatment with target total cholesterol of <4 mmol/l and LDL cholesterol of <2 mmol/L; 3) antihypertensive treatment, if required, with target blood pressure of 135/85 mmHg. Patients will also undergo risk factor modification e.g. advice on smoking. FOLLOW UP The planned duration of follow up is a minimum of 5 years up to a maximum of 10 years. Recruitment and follow up will be supervised by the neurologist or stroke physician. Follow up will include ECG and troponin at 48 hours after revascularisation, with MRI at baseline and at 2 and 5 years follow up. SAMPLE SIZE The planned sample size is 320 patients for the safety MRI analysis and 2000 patients for the full trial. PRIMARY OUTCOME MEASURES For the full trial: any stroke at any time, plus non-stroke death occurring within 30 days of revascularisation. For the safety MRI analysis: The combined 2-year rate of cerebral infarction, cerebral haemorrhage, MI or periprocedural death after randomisation as assessed by follow up MRI and screening for MI. SECONDARY OUTCOME MEASURES Ipsilateral stroke, myocardial infarction, transient ischaemic attack or any hospitalisation for vascular disease during follow up. Disabling stroke during follow up. New cerebral infarction or haemorrhage on post procedural MRI. Ipsilateral restenosis or stenosis progression. Cognitive impairment. Further treatment procedure. Adverse events attributed to medical treatment or CEA. Quality of life and economic measures.